3/28/2025AstraZeneca Advances AZD0120 CAR-T Trial for Lupus

3/28/2025Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...

3/28/2025GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...

3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...

3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment

3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...

3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...

3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...

3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...

3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...

3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...

3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China

3/21/2025Junshi's Toripalimab Receives 11th Approval in China

3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...

3/21/2025Gilead's Trodelvy Receives Second Approval in China

3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...

3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...

3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS

3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients

3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...

3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

Page:14/20 Total number of articles:593: [First][<<] [12] [13] [14] [15] [16] [>>] [End]